Immuneering Corporation (IMRX)
USD 1.62
(-6.36%)
USD 1.62
(-6.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | 316.95 Thousand | 2.07 Million | 2.31 Million | 1.91 Million |
| Cost of Revenue | 764.13 Thousand | 158.12 Thousand | 1.15 Million | 1.28 Million | 1.22 Million |
| Gross Profit | -764.13 Thousand | 158.83 Thousand | 926.88 Thousand | 1.03 Million | 696.73 Thousand |
| Operating Expenses | 58.41 Million | 51.9 Million | 34.81 Million | 18.11 Million | 6.98 Million |
| Selling, General and Administrative Expenses | 16.75 Million | 15.6 Million | 8.27 Million | 3.1 Million | 2.7 Million |
| Research and Development Expenses | 41.4 Million | 36.26 Million | 26.54 Million | 15 Million | 4.27 Million |
| Other Expenses | - | 30.05 Thousand | -127.06 Thousand | - | - |
| Cost and Expenses | 58.41 Million | 52.06 Million | 35.96 Million | 19.39 Million | 8.21 Million |
| Operating Income | -58.41 Million | -51.74 Million | -33.88 Million | -17.08 Million | -6.29 Million |
| Interest Expense | - | 1.01 Million | - | - | 351.3 Thousand |
| Income Tax Expense | - | -1.23 Million | -307.48 Thousand | -84.33 Thousand | 351.3 Thousand |
| Earnings before Tax | -53.47 Million | -50.51 Million | -33.84 Million | -17.03 Million | -7.7 Million |
| Net Income | -53.47 Million | -49.28 Million | -33.53 Million | -17.03 Million | -8.06 Million |
| Earnings Per Share Basic | -1.88 | -1.87 | -1.27 | -0.67 | -0.32 |
| Earnings Per Share Diluted | -1.88 | -1.87 | -1.27 | -0.67 | -0.32 |
| Weighted Average Shares Outstanding | 28.41 Million | 26.38 Million | 26.32 Million | 25.51 Million | 25.51 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.41 Million | 26.38 Million | 26.32 Million | 25.51 Million | 25.51 Million |
| Gross Margin | - | 0.50 | 0.45 | 0.45 | 0.36 |
| EBIT Margin | - | -163.16 | -16.29 | -7.34 | -3.82 |
| Profit Margin | - | -155.49 | -16.12 | -7.37 | -4.20 |
| EBITDA | -58.06 Million | -51.46 Million | -33.68 Million | -17 Million | -7.34 Million |
| Earnings Before Tax Margin | - | -163.26 | -16.29 | -7.39 | -3.28 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | -94.41 Million | - | - | 94.41 Million |
| Cost of Revenue | 175.48 Thousand | 187.68 Thousand | 185.21 Thousand | 764.13 Thousand | 195.78 Thousand | 193.51 Thousand |
| Gross Profit | -175.48 Thousand | -187.68 Thousand | -94.6 Million | -764.13 Thousand | -195.78 Thousand | 94.22 Million |
| Operating Expenses | 14.73 Million | 15.13 Million | 16.3 Million | 57.64 Million | 13.92 Million | 13.5 Million |
| Selling, General and Administrative Expenses | 4.14 Million | 3.99 Million | 4.38 Million | - | 3.86 Million | 4.04 Million |
| Research and Development Expenses | 10.58 Million | 11.14 Million | 11.91 Million | - | 10.05 Million | 9.45 Million |
| Other Expenses | 7717.00 | 213.03 Thousand | 464.35 Thousand | 29.26 Million | 7317.00 | 150.19 Thousand |
| Cost and Expenses | 14.91 Million | 15.32 Million | 16.3 Million | 58.41 Million | 13.92 Million | 13.5 Million |
| Operating Income | -14.91 Million | -15.32 Million | -16.3 Million | -58.41 Million | -13.92 Million | -13.5 Million |
| Interest Expense | - | - | 1.07 Billion | - | - | - |
| Income Tax Expense | -2.00 | -1.00 | -754.65 Thousand | 2.00 | -13.91 Billion | -1.13 Million |
| Earnings before Tax | -14.07 Million | -14.3 Million | -15.08 Million | -53.47 Million | -12.59 Million | -12.18 Million |
| Net Income | -14.07 Million | -14.3 Million | -15.08 Million | -53.47 Million | -12.59 Million | -12.18 Million |
| Earnings Per Share Basic | -0.47 | -0.49 | -0.52 | - | -0.43 | -0.43 |
| Earnings Per Share Diluted | -0.47 | -0.49 | -0.52 | - | -0.43 | -0.43 |
| Weighted Average Shares Outstanding | 29.65 Million | 29.37 Million | 29.26 Million | 28.41 Million | 29.26 Million | 28.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.65 Million | 29.37 Million | 29.26 Million | 28.41 Million | 29.26 Million | 28.64 Million |
| Gross Margin | - | - | 1.00 | - | - | 1.00 |
| EBIT Margin | - | - | 0.17 | - | - | -0.14 |
| Profit Margin | - | - | 0.16 | - | - | -0.13 |
| EBITDA | -14.73 Million | -15.13 Million | -16.2 Million | - | -13.92 Billion | -13.49 Million |
| Earnings Before Tax Margin | - | - | 0.17 | - | - | -0.14 |
NICK
SVM
600293
TRS
BKIRF
NHHHF